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cancer have implicated PTPN14 as a putative tumor suppressor (53) (54) (55) (56) . PTPN14 is mutated in occur along the length of the gene (54, 57) . Several potential substrates for dephosphorylation 1 0 5 by PTPN14 are related to cell growth control (53, 56, 58) . PTPN14 also has phosphatase 1 7 1 that were activated by HPV16 E7 dependent on its ability to degrade PTPN14 were not 1 7 2 significantly enriched for any GO terms (Supplemental Figure 2A ). To test whether repression of keratinocyte differentiation was related to RB1 inactivation 1 7 4 we used HPV16 E7 Δ 21-24 to assess the transcriptional impact of E7 in the absence of RB1 1 7 5 binding. As expected, cell cycle and DNA replication related GO categories were the most 1 7 6 significantly enriched categories among genes differentially regulated by HPV16 E7 WT versus 1 7 7 HPV16 E7 Δ 21-24 ( Figure 2C, Top) . In contrast, comparing HPV16 E7 Δ 21-24 to empty vector 1 7 8 control identified the genes that are repressed by HPV16 E7 independent of RB1 binding 1 7 9
( Figure 2C , Bottom). GO analysis of these genes identified the same keratinocyte 1 8 0 differentiation-related gene sets that were seen in our analysis of PTPN14 degradation WT dependent on its ability to degrade PTPN14. We concluded that repression of keratinocyte 1 8 4 differentiation through the degradation of PTPN14 was independent of RB1 binding. In the 1 8 5 8 absence of RB1 binding HPV16 E7 acted mainly as a repressor but retained a modest ability to 1 8 6 promote gene expression (Supplemental Figure 2B ). To better understand the impacts of PTPN14 degradation on gene expression, we 1 8 8 examined individual genes significantly lower in HPV16 E7 WT cells than in HPV16 E7 E10K 1 8 9 cells. Many of the genes that are repressed by HPV16 E7 WT and HPV16 E7 Δ 21-24 but not by 1 9 0 HPV16 E7 E10K are described by epidermis development and more specific GO terms 1 9 1 (Supplemental Figure 2D , Supplemental Table 2 ). Although certain genes were not repressed 1 9 2 by either HPV16 E7 E10K or HPV16 E7 Δ 21-24, these genes were largely related to other 1 9 3 biological processes. To validate the results obtained from RNA-seq, we used qRT-PCR to confirm the altered 1 9 5 expression of several genes related to keratinocyte differentiation in our cell lines. Markers of 1 0 this idea, since HPV16 E7 E10K and HPV6 E7 both interact with PTPN14 and they repressed 2 3 7 differentiation to similar levels.
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In addition to stimulating differentiation, growth in suspension activates the Hippo 2 3 9 signaling pathway (68, 69) which represses the transcription of the well characterized 2 4 0 YAP/TEAD targets CTGF and CYR61. PTPN14 knockdown in MCF10A cells has been shown 2 4 1 to induce the transcription of CTGF and CYR61 (59). Since PTPN14 has been characterized as 2 4 2 a negative regulator of YAP1 and shown to regulate CTGF and CYR61 in other cell types (55, 2 4 3 59-61), we measured these transcripts to determine whether E7 differentially impacts their 2 4 4 expression. Compared to vector controls, none of the E7 cell lines exhibited altered expression 2 4 5 of these YAP1/TEAD targets before or after detachment ( Figure 3B ).
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To further assess cell viability in the detachment experiment, 1,000 cells were taken 2 4 7 from suspension culture, re-plated in coated tissue culture plates, and allowed to grow for 5d. HPV16 E7 protected against cell death following detachment in a manner that was dependent 2 4 9 on the ability of E7 to target PTPN14 for degradation ( Figure 3C ). This is consistent with 2 5 0 previous reports demonstrating that HPV16 E7 and BPV E7 require UBR4 to protect cells 2 5 1 against cell death triggered following detachment from a substrate (46, 67). To test what cellular processes are affected when PTPN14 levels are reduced in human 2 5 5 keratinocytes, we performed an unbiased analysis of gene expression in the presence and 2 5 6 absence of PTPN14. Primary HFK were transduced with lentiviral vectors encoding SpCas9 2 5 7 plus an sgRNA targeting PTPN14 (sgPTPN14-3) or a nontargeting control sgRNA (sgNT-2), 2 5 8 then selected with puromycin to generate control (HFK-control) and PTPN14-deleted (HFK- PTPN14 KO) cell lines ( Figure 4A ). Total RNA was isolated from two or three independent 2 6 0 isolates of HFK-control and HFK-PTPN14 KO, then polyA selected RNA was subjected to RNA-2 6 1 seq. In cells that did not express PTPN14, 141 genes were differentially regulated with fold 2 6 2 1 1 change ≥1.5 and adjusted p-value ≤0.05. Of these 29 genes were up-regulated and 112 were 2 6 3 down-regulated in the absence of PTPN14 ( Figure 4B and Supplemental Table 3 ). Thus, 2 6 4 PTPN14 appeared to act largely to promote, rather than to repress, gene expression. As in the 2 6 5 analysis of the HPV16 E7 variants, keratinocyte differentiation-related GO terms were 2 6 6 downregulated in PTPN14 KO cells ( Figure 4C , Figure 2A and C). More than half of the down- GO categories ( Figure 4D ). There was not a corresponding enrichment in differentiation-related 2 6 9 GO terms among the up-regulated genes; however, one GO category, inflammatory response, We hypothesized that individual genes might be similarly regulated by PTPN14 KO and 2 7 2 E7-mediated PTPN14 degradation. Indeed, the genes that were both downregulated by 2 7 3 PTPN14 loss and downregulated by HPV16 E7 WT in a PTPN14 degradation-dependent 2 7 4 manner are involved in keratinocyte differentiation ( Figure 2B ). Furthermore, gene expression PTPN14 KO and cells expressing HPV16 E7 variants is consistent with degradation of PTPN14 2 7 8 by HPV16 E7 acting to inhibit keratinocyte differentiation. Our data suggest that PTPN14 2 7 9 degradation mediates the predominant RB-independent effect of HPV16 E7 on gene
We selected a subset of genes for validation by qRT-PCR. In agreement with the RNA- and DSC1 were expressed at 3-to 12-fold lower levels in the absence of PTPN14 ( Figure 4E ). types, we found that PTPN14 loss did not impact the expression of the well-characterized 2 8 8 1 2 YAP/TEAD targets CTGF and CYR61 ( Figure 4G ). These data support the idea that PTPN14 2 8 9 loss impairs the regulation of keratinocyte differentiation but does not affect expression of 2 9 0 canonical Hippo regulated genes in primary HFK. Having determined that PTPN14 loss reduces the basal expression of keratinocyte 2 9 4 differentiation-related genes, we next tested whether PTPN14 loss alters the cellular response 2 9 5 to a differentiation stimulus. We used CRISPR-Cas9 gene editing in N/Tert-1 cells to engineer we stimulated these cells to differentiate through growth in low adherence plates for 12h. Consistent with the effect in primary cells, PTPN14 KO reduced the expression of KRT16 and 2 9 9 IVL in adherent cells. We further found that PTPN14 loss also impaired the expression of Finally, we used cell growth after re-plating as a measure of viability after detachment.
The N/Tert-PTPN14 KO cells exhibited improved survival and colony formation after 3 0 7 detachment compared to control cells ( Figure 5C ). This is consistent with the result that HPV E7 Coexpression of HPV16 E6 and E7 can efficiently immortalize primary keratinocytes in 3 1 5 cell culture. To determine whether PTPN14 degradation is required for immortalization by 3 1 6 HPV16 oncoproteins, primary HFK were transduced with pairs of HPV E6/E7-encoding 3 1 7 retroviruses, selected with puromycin and blasticidin, and monitored for cell growth over the 3 1 8 next 17 passages -equivalent to 75 days for WT HPV16 E6/E7 cells ( Figure 6 ). Primary HFK transduced with HPV6 E6/E7 or with empty vector controls rapidly 3 2 0 senesced, while cells transduced with HPV16 E6/E7 were immortalized in 3/3 replicate expressing vectors retained some proliferative capacity, but their growth was reproducibly 3 2 5 impaired compared to that of HPV16 E6/E7 WT cells. We hypothesize that these cells are not 3 2 6 fully immortalized and that both RB1 inactivation and PTPN14 degradation are required for 3 2 7 immortalization of primary HFK by HPV E6 and E7. The changes in differentiation-related gene expression in HPV E7-expressing cell lines 3 3 2 appeared to be dependent on the ability of E7 to degrade PTPN14 and to reflect the same also correlates with its ability to immortalize primary HFK. We wished to determine whether E7- HPV-negative (75-77). Genes that were differentially expressed by 3-fold or more in HPV- Strikingly, the most enriched GO terms among genes downregulated in HPV+ cancers 3 4 1 relative to HPV-cancers were epidermis development, keratinocyte differentiation, and 3 4 2 epidermal cell differentiation ( Figure 7A ). As in the PTPN14 knockout cells and in the presence 3 4 3 of HPV16 E7, downregulated genes reflected a keratinocyte differentiation signature. Furthermore, many of the other highly enriched GO terms were related to more general 3 4 5 developmental processes. In total, epidermis development and other developmental processes Our previous finding that PTPN14 is targeted for degradation by high-risk HPV E7 but risk HPV (47). PTPN14 is a candidate tumor suppressor based on the observation that it is 3 5 7 mutated in some cancers (54, 57, (78) (79) (80) (81) . The targeted degradation of PTPN14 by high-risk 3 5 8 HPV E7 requires the E3 ubiquitin ligase UBR4 and the interaction of UBR4 with papillomavirus 3 5 9 1 5 hypothesis was that E7-mediated PTPN14 degradation would activate YAP1 and promote the 3 6 7 expression of pro-proliferative YAP target genes such as CTGF and CYR61. However, we have 3 6 8 not identified any cell type in which high-risk HPV E7 expression causes an increase in CTGF or 3 6 9 CYR61 RNA. In addition, we found that depletion or knockout of PTPN14 in human 3 7 0 keratinocytes did not cause CTGF or CYR61 upregulation (Figures 4 and 5) . However, our cell 3 7 1 detachment experiments suggested that these genes are indeed regulated by Hippo signaling in In the absence of support for this initial hypothesis, we took an unbiased approach to 3 7 5 determine the effect of high-risk HPV E7-mediated PTPN14 degradation in keratinocytes. By using an HPV16 E7 variant that cannot degrade PTPN14 (Figures 1 and 2) and by directly 3 7 7 testing the effect of PTPN14 knockout in primary HFK (Figure 4 ), we determined that PTPN14 with this idea, PTPN14 appears to be a target of regulation by p53 in mouse cells, but is likely a 3 8 0 p63 target in human cells (79, (86) (87) (88) . p63 is a master regulator of epidermal development (89). The link between PTPN14 and differentiation directly connected PTPN14 degradation to HPV To further test how high-risk HPV E7-mediated PTPN14 degradation affects processes 3 8 4 related to epidermal cell differentiation, we used a keratinocyte detachment and re-plating assay 3 8 5 ( Figure 3 ). Our studies indicated that high-risk HPV E7 inhibit the expression of differentiation anoikis and proliferate in the absence of contact with the basement membrane is a hallmark of 3 9 0 cancer cells. The E7 proteins that inhibited differentiation marker gene expression promoted cell 3 9 1 survival following detachment and this correlated with the ability to degrade PTPN14 (Figure 3) . In support of the notion that E7 mediated PTPN14 degradation contributes to oncogenic 3 9 3 transformation, our subsequent experiments indicated that PTPN14 degradation by high-risk 3 9 4 HPV contributes to keratinocyte immortalization. Primary keratinocytes were fully immortalized 3 9 5 by HPV16 E6/E7 but not by HPV16 E6/E7 E10K ( Figure 6) . In transcriptional profiles of human 3 9 6 head and neck cancer samples, changes in gene expression consistent with PTPN14 loss were 3 9 7 reflected in HPV-positive but not HPV-negative cancers (Figure 7) . Strikingly, we found that the 3 9 8 gene ontology terms related to keratinocyte differentiation and epidermis development 3 9 9 described both the PTPN14-dependent differential gene expression in primary cells and the 4 0 0 most significant differences between HPV-positive and HPV-negative head and neck 4 0 1 carcinomas. We also observed that in previously published data these same GO terms were Some previous studies suggested that differentiation inhibition by E7 could be RB/E2F- analysis clearly showed that much of the E7-mediated repression of differentiation is 4 1 5 independent of RB binding. Here we have focused on the genes repressed by HPV16 E7, which 4 1 6 includes many markers of keratinocyte differentiation that were also downregulated upon 4 1 7 PTPN14 knockout (Figures 2 and 4) . Using the HPV16 E7 ∆ 21-24 mutant we have found that 4 1 8 1 7 RB1 binding is not required for the repression of most of these genes (Figure 2 ). RB1 binding 4 1 9 did allow for the repression of some differentiation genes by HPV16 E7 (Supplemental Figure   4 2 0 2D) and certain genes upregulated by HPV16 E7 but not by HPV16 E7 ∆ 21-24 were related to 4 2 1 keratinocyte differentiation. Nonetheless, differentiation-related GO terms comprised a minor 4 2 2 part of the HPV16 E7 gene induction signature whereas they were the most significant terms repressed by HPV16 E7 in the presence or absence of RB1 binding. All HPVs, not only the high-risk types, likely manipulate differentiation in order to 4 2 5 replicate. PTPN14 is a conserved interactor of HPV E7 suggesting an evolutionary pressure to 4 2 6 maintain this interaction regardless of the ability to direct it for proteasomal degradation. Our 4 2 7 future studies will address whether low-risk HPV E7 impact keratinocyte differentiation via their 4 2 8 ability to bind to (but not degrade) PTPN14. Our study supports this hypothesis as the HPV16 HPV discussed here, do not engage MAML1 in the same way. It is interesting to speculate that 4 3 5 all HPV promote proliferation but that pathogenesis is related to their ability to further impair 4 3 6 differentiation: via the E7-PTPN14 interaction in the case of mucosal, genus alpha HPV and via 4 3 7 the E6-MAML interaction in the case of cutaneous, genus beta HPV. The binding and degradation of RB1 is a major component of high-risk HPV E7-4 3 9 mediated transformation. However, many observations have suggested that there must be RB1-4 4 0 independent contributions to E7-mediated transformation. We propose that PTPN14 to impair differentiation or whether PTPN14 degradation has additional oncogenic effects. In 4 4 6 either case, the identification of a mechanism by which HPV E7 controls differentiation is 4 4 7 significant. The potential of differentiation therapy has been validated by the highly successful 4 4 8 use of all-trans retinoic acid to treat acute promyelocytic leukemia (95). It is tantalizing to 4 4 9 speculate that inhibiting PTPN14 inactivation could similarly restore the cellular differentiation 4 5 0 program in HPV-positive cancer cells and have therapeutic potential. Our future work will aim to 4 5 1 elucidate the mechanism of PTPN14 signal transduction in keratinocytes and to further 4 5 2 characterize the role of PTPN14 degradation in HPV replication and in HPV-associated cancers. Harvard Medical School) and hTert-immortalized HFK (63) were cultured as previously Table   4 6 3 4). Retroviruses and lentiviruses were generated as previously described (96). re-plated in ultra-low attachment plates (Sigma-Aldrich CLS3471). After 0 or 12h of culture in 4 6 7 suspension cells were harvested for RNA analysis or 1000 cells were re-plated in standard 6-4 6 8 well tissue culture plates. Re-plated cells were stained with crystal violet 5 days post re-plating. To assess the ability of HPV16 E7 variants to support keratinocyte immortalization, Western blots were performed as previously described (47) Systems), and UBR4 (gift of Dr. Yoshihiro Nakatani, Dana-Farber Cancer Institute (98)).
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Membranes were washed in TBS-T and incubated with horseradish peroxidase (HRP)-coupled 4 9 1 anti-mouse or anti-rabbit antibodies or an Alexa-680 coupled anti-mouse antibody and detected 4 9 2 using Western Lightning chemiluminescent substrate or a Li-COR Infrared imaging system. HA-4 9 3 tagged proteins were detected using an HA antibody conjugated to HRP (Roche) and visualized 4 9 4 2 0 in the same way.
For anti-HA immunoprecipitations, HA-tagged proteins were 4 9 5 immunoprecipitated and processed for Western blot as previously described (47). Total RNA was isolated from 2-3 independent isolates of HFK-control, HFK-PTPN14 KO, 4 9 9
HFK-empty vector control, or HFK E7 cells using the RNeasy mini kit (Qiagen). PolyA selection, 5 0 0 reverse transcription, library construction, sequencing, and initial analysis were performed by 5 0 1
Novogene. Differentially expressed genes were selected based on a 1.5-fold change and Total RNA was isolated from N/Tert cells using the NucleoSpin RNA extraction kit 5 0 9
(Macherey-Nagel). RNA was then reverse transcribed using the High Capacity cDNA Reverse 5 1 0
Transcription Kit (Applied Biosystems). cDNAs were assayed by qPCR using Fast SYBR Green 5 1 1
Master Mix (Applied Biosystems) using a QuantStudio 3 -96-Well, 0.2 mL Block instrument 5 1 2 (ThermoFisher). All gene RT-qPCR data were normalized to GAPDH or to G6PD. qRT-PCR 5 1 3 primer sequences are listed in Supplemental Table 4 . 
